uniQure (QURE) EBITDA Margin Growth (1y) (2017 - 2026)
uniQure (QURE) EBITDA Margin Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
uniQure |
2.88 Bn |
2.88 Bn |
3.34 Mn |
129,925.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
129,925.00 |
| Dec 31, 2025 |
67,188.00 |
| Sep 30, 2025 |
-21,463.00 |
| Jun 30, 2025 |
-30,519.00 |
| Mar 31, 2025 |
-204,621.00 |
| Dec 31, 2024 |
-30,894.00 |
| Sep 30, 2024 |
484,395.00 |
| Jun 30, 2024 |
231,643.00 |
| Mar 31, 2024 |
53,873.00 |
| Dec 31, 2023 |
-106,001.00 |
| Sep 30, 2023 |
-174,730.00 |
| Jun 30, 2023 |
1.07 Mn |
| Mar 31, 2023 |
184,654.00 |
| Dec 31, 2022 |
4,520.00 |
| Sep 30, 2022 |
-254,890.00 |
| Jun 30, 2022 |
-1.36 Mn |
| Mar 31, 2022 |
763,056.00 |
| Dec 31, 2021 |
-2,496.00 |
| Sep 30, 2021 |
-3,838.00 |
| Jun 30, 2021 |
255,394.00 |
